Aspirin responsiveness in acute brain ischaemia: Association with stroke severity and clinical outcome

Cerebrovascular Diseases

Volumn 25, Issue 4, 2008, Pages 355-361

  Schwammenthal, Y ^a   Tsabari, R ^a   Shenkman, B ^a   Schwartz, R ^a   Matetzky, S ^a   Lubetsky, A ^a   Orion, D ^a   Israeli Korn, S ^a   Chapman, J ^a   Savion, N ^a,c   Varon, D ^b   Tanne, D ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Acute stroke; Antiplatelet therapy; Platelet aggregation

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; ANALYTIC METHOD; ANALYZER; ARTICLE; BRAIN ISCHEMIA; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STROKE; THROMBOCYTE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ASPIRIN; BLOOD PLATELETS; BRAIN ISCHEMIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; SEVERITY OF ILLNESS INDEX; STROKE; TREATMENT OUTCOME;

EID: 42349084776     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000118382     Document Type: Article

References (28)

1. Joseph R, D'Andrea G, Oster S, Welch K: Whole blood platelet function in acute ischemic stroke. Importance of dense body secretion and effects of antithrombotic agents. Stroke 1989;20:38-44.
2. van Kooten F, Ciabattoni G, Patrono C, Dippel DWJ, Koudstaal PJ: Platelet activation and lipid peroxidation in patients with acute ischemic stroke. Stroke 1997;28:1557-1563.
3. Yi HK, Liou CW, Chang HW, Lan MY, Liu JS, Chen MC: Link between platelet activity and outcomes after an ischemic stroke. Cerebrovasc Dis 2005;20:120-128.
4. International Stroke Trial Collaborative Group: The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke. Lancet 1997;349:1569-1581.
5. Chen Z-M: CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet 1997;349:1641-1649.
6. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P: Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:483S-512S.
7. Wilterdink JL, Bendixen B, Adams HP Jr, Woolson RF, Clarke WR, Hansen MD: Effect of prior aspirin use on stroke severity in the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Stroke 2001;32:2836-2840.
8. Sanossian N, Saver JL, Rajajee V, et al: Premorbid antiplatelet use and ischemic stroke outcomes. Neurology 2006;66:319-323.
9. Ricci S, Lewis S, Sandercock P: Previous use of aspirin and baseline stroke severity. Stroke 2006;37:1737-1740.
10. Herndon R: Handbook of Neurologic Rating Scales. New York, Demos Vermande, 1997.
11. Michelson AD, Cattaneo M, Eikelboom JW, et al: Aspirin resistance: position paper of the Working Group on Aspirin Resistance. J Thromb Haemost 2005;3:1309-1311.
12. Spectre G, Brill A, Gural A, et al: A new point-of-care method for monitoring antiplatelet therapy: application of the cone and plate(let) analyzer. Platelets 2005;16:293-299.
13. Varon D, Dardik R, Shenkman B, et al: A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions. Thromb Res 1997;85:283-294.
14. Gum PA, Kottke-Marchant K, Welsh PA, White J, Topol EJ: A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 2003;41:961-965.
15. Grotemeyer KH: Effects of acetylsalicylic acid in stroke patients. Evidence of nonresponders in a subpopulation of treated patients. Thromb Res 1991;63:587-593.
16. Cipollone F, Patrignani P, Greco A, et al: Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. Circulation 1997;96:1109-1116.
17. Zimmermann N, Wenk A, Kim U, et al: Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery. Circulation 2003;108:542-547.
18. Harrison P, Segal H, Blasbery K, Furtado C, Silver L, Rothwell PM: Screening for aspirin responsiveness after transient ischemic attack and stroke: comparison of 2 point-of-care platelet function tests with optical aggregometry. Stroke 2005;36:1001-1005.
19. Grotemeyer KH, Scharafinski HW, Husstedt IW: Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients. Thromb Res 1993;71:397-403.
20. Eikelboom JW, Hirsh J, Weitz JI, Johnston M, Yi Q, Yusuf S: Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation 2002;105:1650-1655.
21. Grundmann K, Jaschonek K, Kleine B, Dichgans J, Topka H: Aspirin non-responder status in patients with recurrent cerebral ischemic attacks. J Neurol 2003;250:63-66.
22. Snoep JD, Hovens MM, Eikenboom JC, et al: Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events. Arch Intern Med 2007;167:1593-1599.
23. Choudhri TF, Hoh BL, Zerwes HG, et al: Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation. J Clin Invest 1998;102:1301-1310.
24. Weimar C, Mieck T, Buchthal J, et al: Neurologic worsening during the acute phase of ischemic stroke. Arch Neurol 2005;62:393-397.
25. Helgason CM, Tortorice KL, Winkler SR, et al: Aspirin response and failure in cerebral infarction. Stroke 1993;24:345-350.
26. Gum PA, Kottke-Marchant K, Poggio ED, et al: Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol 2001;88:230-235.
27. Hankey GJ, Eikelboom JW: Aspirin resistance. Lancet 2006;367:606-617.
28. Markus HS, Droste DW, Kaps M, et al: Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation 2005;111:2233-2240.